ARA-290 20mg

$100

Request COA

Highlights

  • Erythropoietin-derived peptide studied for inflammatory signaling pathways
  • Research explores effects on metabolic and neural markers in preclinical models
  • Non-erythropoietic; for research use only

 

Description

ARA-290 is a synthetic peptide derived from the beta-helix region of erythropoietin, studied for its role in modulating inflammatory pathways through innate repair receptors. Preclinical and early-stage research has examined its effects on metabolic and neural markers, without influencing red blood cell production. For laboratory research use only.

All compounds sold by Standard Protocol Sciences are intended for research use only. Not for human consumption. For use by trained researchers in controlled laboratory settings only. Keep out of reach of children.

Search
×